NCT03293758

Brief Summary

The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16,000

participants targeted

Target at P75+ for all trials

Timeline
103mo left

Started May 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
May 2016Dec 2034

Study Start

First participant enrolled

May 16, 2016

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

September 22, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 26, 2017

Completed
12.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2029

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2034

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

13.6 years

First QC Date

September 22, 2017

Last Update Submit

February 23, 2026

Conditions

CancerCardiovascular Diseases

Outcome Measures

Primary Outcomes (1)

  • Demographic

    sex, race, education, oral health status, lifestyle, medical history, anthropometry, and medication use will be collected using the baseline questionnaire at enrolment. The collected information will provide risk stratification information for statistical control in studies of colorectal tumors and other major chronic diseases.

    5 Years

Secondary Outcomes (1)

  • Differences in human microbiota between subjects with colorectal adenoma or colorectal cancer and those without.

    5 Years

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects in the United States identified at NYU clinics, community organizations, and online participant databases.

You may qualify if:

  • Age \> 40

You may not qualify if:

  • Use of long term antibiotics.
  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

RECRUITING

MeSH Terms

Conditions

NeoplasmsCardiovascular Diseases

Study Officials

  • Jiyoung Ahn, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zelle Halloran

CONTACT

646-501-3673Zelle.Halloran@nyulangone.org

Jiyoung Ahn, PhD

CONTACT

646-501-3373jiyoung.ahn@nyulangone.org

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2017

First Posted

September 26, 2017

Study Start

May 16, 2016

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2034

Last Updated

February 25, 2026

Record last verified: 2026-02

Locations

US(1)